Clinical trial
Efficacy of Pancrelipase on Postprandial Belching and Bloating.
NCT00266721 · Solvay Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00266721 |
|---|---|
| Title | Efficacy of Pancrelipase on Postprandial Belching and Bloating. |
| Lead sponsor | Solvay Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Postprandial Bloating, Postprandial Belching, Postprandial Eructation |
| Intervention type | Drug |
| Interventions | Pancrelipase (Creon) 2 tablets with each meal |
| Enrollment | 45 |
| Start date | Jan 1, 2000 |
| Completion | Oct 1, 2000 |
| First posted | Dec 19, 2005 |
| Last update posted | Dec 19, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: